Journal
NATURE
Volume 602, Issue 7896, Pages 314-+Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41586-021-04356-8
Keywords
-
Categories
Funding
- National Institute of Allergy and Infectious Diseases (NIAID
- National Institutes of Health ) [K99AI159136, U19AI082724, U19AI109946, U19AI057266, P01AI097092, R01AI145870-01, R21AI146529, T32AI007244-36]
- NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400005C, HHSN272201400008C]
- NIAID Centers of Excellence for Influenza Research and Response (CEIRR) [75N93019R00028]
- NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) [75N93019C00051]
- Bill and Melinda Gates Foundation [OPP1084518]
- Austrian Science Fund [P34518]
- Bill and Melinda Gates Foundation [OPP1084518] Funding Source: Bill and Melinda Gates Foundation
Ask authors/readers for more resources
A new class of broadly neutralizing antibodies has been discovered that can target multiple strains of influenza viruses, including potential pandemic threats. These antibodies utilize specific epitopes for neutralization, which is crucial for the design of universal influenza virus vaccines. It is found that antibodies targeting these epitopes are widespread in the human body.
Broadly neutralizing antibodies that target epitopes of haemagglutinin on the influenza virus have the potential to provide near universal protection against influenza virus infection(1). However, viral mutants that escape broadly neutralizing antibodies have been reported(2,3). The identification of broadly neutralizing antibody classes that can neutralize viral escape mutants is critical for universal influenza virus vaccine design. Here we report a distinct class of broadly neutralizing antibodies that target a discrete membrane-proximal anchor epitope of the haemagglutinin stalk domain. Anchor epitope-targeting antibodies are broadly neutralizing across H1 viruses and can cross-react with H2 and H5 viruses that are a pandemic threat. Antibodies that target this anchor epitope utilize a highly restricted repertoire, which encodes two public binding motifs that make extensive contacts with conserved residues in the fusion peptide. Moreover, anchor epitope-targeting B cells are common in the human memory B cell repertoire and were recalled in humans by an oil-in-water adjuvanted chimeric haemagglutinin vaccine(4,5), which is a potential universal influenza virus vaccine. To maximize protection against seasonal and pandemic influenza viruses, vaccines should aim to boost this previously untapped source of broadly neutralizing antibodies that are widespread in the human memory B cell pool.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available